Bolt Biotherapeutics, Inc. Common Stock (BOLT) is a publicly traded Healthcare sector company. As of August 11, 2026, BOLT trades at $4.05 with a market cap of $7.78M and a P/E ratio of -0.24. BOLT moved +0.00% today. Year to date, BOLT is -27.03%; over the trailing twelve months it is -28.37%. Its 52-week range spans $3.75 to $12.60. Analyst consensus is strong buy with an average price target of $34.67. Rallies surfaces BOLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bolt Biotherapeutics, Inc. Common Stock (BOLT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BOLT moved +0.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $4.05 |
| Market Cap | $7.78M |
| P/E Ratio | -0.24 |
| EPS | $-16.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.60 |
| 52-Week Low | $3.75 |
| Volume | 5.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.50M |
| Net Income | $-29.58M |
| Gross Margin | 0.00% |
4 analysts cover BOLT: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.67.